Abstract: A simulation apparatus is disclosed, including a group switching part. The group switching part refers to a priority management table, which manages priority information of priorities to assign a CPU for multiple groups of tasks stored in a storage area, and changes the priorities of the multiple groups of tasks, when an event occurs to activate a task to be executed in verifying of software by using a simulation.

Abstract: A simulation apparatus is disclosed, including a hardware simulator and a CPU model. The hardware simulator activates one or more logical hardware models for verifying embedded software. The CPU model is one of the one or more logical hardware models which imitates a CPU which executes the embedded software, and to trigger the embedded software to operate without synchronization for each of instructions.

Abstract: A simulation apparatus is disclosed, including a group switching part. The group switching part refers to a priority management table, which manages priority information of priorities to assign a CPU for multiple groups of tasks stored in a storage area, and changes the priorities of the multiple groups of tasks, when an event occurs to activate a task to be executed in verifying of software by using a simulation.

Abstract: A simulation apparatus is disclosed, including a hardware simulator and a CPU model. The hardware simulator activates one or more logical hardware models for verifying embedded software. The CPU model is one of the one or more logical hardware models which imitates a CPU which executes the embedded software, and to trigger the embedded software to operate without synchronization for each of instructions.

Abstract: A head suspension assembly 10 wherein a tube 5, through which pass a plurality of covered wires 4, is clamped with a securing unit 6, a space between the covered wires 4 and the tube 5 is filled with a filler 7. The part of the tube 5 that is filled with filler 7 is clamped with securing unit 6. The securing unit 6 preferably is a claw section on the head suspension assembly. It is preferable that the tube 5is able to transmit light and the filler 7 can be cured by light.

Abstract: A method for fixedly attaching covered wires to a load beam during the manufacturing of a head suspension assembly in order to provide an electrical connection to a head slider. The method includes the steps of passing the covered wires through a transparent tube, inserting a filler into the tube at a point where clamping is required, curing the filler, visually identifying the filer location, and clamping the tube at the filer location.

Abstract: A head suspension assembly 10 wherein a tube 5, through which pass a plurality of covered wires 4, is clamped with a securing unit 6. A space between the covered wires 4 and the tube 5 is filled with a filler 7. The part of the tube 5 that is filled with filler 7 is clamped with securing unit 6. The securing unit 6 preferably is a claw section on the head suspension assembly. It is preferable that the tube 5 is able to transmit light and the filler 7 can be cured by light.

Abstract: An infrared remote control signal is entered into a receiving circuit where it is converted into an electrical, modulated signal made up of a carrier and a command signal. The modulated input signal is sent to a control signal output circuit where it is filtered to send only the carrier of the remote input signal to a frequency-voltage conversion circuit. The frequency-voltage conversion circuit generates a control DC voltage according to the carrier frequency. The control DC voltage changes the pass band characteristic of a voltage-controlled filter in such a manner that the voltage-controlled filter selectively passes the desired fundamental frequency component and harmonic components of the carrier signal. The voltage-controlled filter also passes the command signal component. Thus, at the output of the voltage-controlled filter is obtained a modulated output signal whose carrier frequency is varied from that of the modulated input signal.

Abstract: A cinnamoylamide derivative of general formula: ##STR1## [wherein, (i) in case that R.sup.2 represents a methyl group and R.sup.3 represents a hydrogen atom,(R.sup.1).sub.n represents a group selected out of3-pentyl group,4-pentyl group,4-neopentyl group,4-(2-ethylbutyl) group,4-(2-methylpentyl) group,2-fluoro-4-pentyloxy group,4-butylthio group,4-cyclobutylmethyl group,4-cyclohexylmethyl group,4-(4-phenylbutyl) group and4-phenoxy group, and(ii) in case that R.sup.2 represents a hydrogen atom and R.sup.3 represents a methyl group,(R.sup.1).sub.n represents a group selected out of3-pentyl group and4-phenethyl group.]or non-toxic salts thereof possess an inhibitory activity on 5.alpha.-reductase, and therefore be useful for treating and/or preventing agent for alopecia, acnes or prostatic hypertrophy.

Abstract: A cinnamoylamide derivative of general formula: ##STR1## [wherein, (i) in case that R.sup.2 represents a methyl group and R.sup.3 represents a hydrogen atom,(R.sup.1).sub.n represents a group selected out of3-pentyl group,4-pentyl group,4-neopentyl group,4-(2-ethylbutyl) group,4-(2-methylpentyl) group,2-fluoro-4-pentyloxy group,4-butylthio group,4-cyclobutylmethyl group,4-cyclohexylmethyl group,4-(4-phenylbutyl) group and4-phenoxy group, and(ii) in case that R.sup.2 represents a hydrogen atom and R.sup.3 represents a methyl group,(R.sup.1).sub.n represents a group selected out of3-pentyl group and4-penethyl group.]or non-toxic salts thereof possess an inhibitory activity on 5.alpha.-reductase, and therefore be useful for treating and/or preventing agent for alopecia, acnes or prostatic hyperfrophy.

Abstract: A cinnamoylamide derivative of general formula: ##STR1## [wherein, (i) in case that R.sup.2 represents a methyl group and R.sup.3 represents a hydrogen atom,(R.sup.1).sub.n represents a group selected out of3-pentyl group,4-pentyl group,4-neopentyl group,4-(2-ethylbutyl) group,4-(2-methylpentyl) group,2-fluoro-4-pentyloxy group,4-butylthio group,4-cyclobutylmethyl group,4-cyclohexylmethyl group,4-(4-phenylbutyl) group and4-phenoxy group, and(ii) in case that R.sup.2 represents a hydrogen atom and R.sup.3 represents a methyl group,(R.sup.1).sub.n represents a group selected out of3-pentyl group and4-phenethyl group.]or non-toxic salts thereof possess an inhibitory activity on 5.alpha.-reductase, and therefore be useful for treating and/or preventing agent for alopecia, acnes or prostatic hypertrophy.

Abstract: A head suspension load beam for a disk file has a slender base portion shaped like a plate, one end of which is secured to a head actuator arm, and the other end of which supports a head. The base portion is reinforced by bending a side margin portion in the longitudinal direction of the base portion at substantially right angles to the plane of the base portion, and further by providing reinforcement ribs, the height of which does not exceed the height of the bent side margin portion, almost parallel to the side margin portion. A head suspension load beam of another embodiment of this invention is reinforced by bending the side margin portion substantially parallel with the plane of the base portion or further toward the plane of the base portion, instead of using reinforcement ribs.

Abstract: A benzoylaminophenoxybutanoic acid derivative of general formula: ##STR1## [wherein R.sup.1 represents hydrogen atom or alkyl group of from 1 to 4 carbon atoms(s),A represents oxygen atom, sulfur atom or sulfinyl (SO) group, two R.sup.1 s represents methyl groups or chlorine atoms at the same time or cyclopentane, cyclohexane or benzene ring together with the carbon atoms of benzene ring each attaching,R.sup.2 represents a group of general formula: ##STR2## {wherein B represents oxygen atom, sulfur atom or a group of general formula:NR.sup.11 (wherein R.sup.11 represents hydrogen atom or alkyl group of from 1 to 4 carbon atom(s)),R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 represent, independently, hydrogen atom, alkyl group of from 1 to 4 carbon atom(s) halogen atom, trifluoromethyl group or cyclobutylmethyl group,m represents 0 or 1,n represents an integer of from 1 to 5, andR.sup.9 and R.sup.

Abstract: A benzoylaminophenoxybutanoic acid derivative of general formula: ##STR1## [wherein A represents oxygen atom, sulfur atom or sulfinyl (SO) group,R.sup.1 represents hydrogen atom or methyl group,R.sup.2 represents a group of the general formula: ##STR2## {wherein B represents oxygen atom, sulfur atom or a group of general formula: NR" (wherein R" represents hydrogen atom or alkyl group of from 1 to 4 carbon atoms(s)), R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 represent, independently, hydrogen atom, alkyl group of from 1 to 4 carbon atom(s), halogen atom or trifluoromethyl group,m represents 0 or 1,n represents an integer of from 1 to 4, andR.sup.9 and R.sup.10 represent, independently, hydrogen atom, alkyl group of from 1 to 5 carbon atom(s) or a group of general formula: ##STR3## (wherein R.sup.12, R.sup.13, R.sup.14 and R.sup.15 represent, independently, hydrogen atom, alkyl group of from 1 to 4 carbon atom(s), halogen atom or trifluoromethyl group, and 1 represents an integer of from 1 to 4.

Abstract: A cinnamoylamide derivative of general formula: ##STR1## [wherein, (i) R.sup.1, R.sup.2 and R.sup.3 each represents, same or different, a halogen atom, straight-chain or branched-chain alkoxy group of from 1 to 7 carbon atom(s), straight-chain or branched-chain alkyl group of from 1 to 7 carbon atom(s) or nitro group, and one of R.sup.4 and R.sup.5 represents a methyl group and the other represents a hydrogen atom, or(ii) one of R.sup.1, R.sup.2 and R.sup.3 represents a group selected out of4-isobutyl group,4-butyl group,4-propyl group,4-butoxy group and4-sec-butyl group, and the other two represent a hydrogen atom,R.sup.4 represents a methyl group andR.sup.5 represents a hydrogen group.]and non-toxic salts thereof possess an inhibitory activity on 5.alpha.-reductase, and therefore is useful for treating and/or preventing agent for alopecia acnes or prostatic hypertrophy.

Abstract: The rhodanine derivatives of the general formula: ##STR1## [wherein (I) R.sup.1 and R.sup.2 are taken together to represent a tetramethylene or pentamethylene group; (II) R.sup.1 represents a hydrogen atom, and R.sup.

Abstract: The rhodanine derivatives of the general formula: ##STR1## [wherein (I) R.sup.1 and R.sup.2 are taken together to represent a tetramethylene or pentamethylene group; (II) R.sup.1 represents a hydrogen atom, and R.sup.

Abstract: The rhodanine derivatives of the general formula: ##STR1## wherein (I) R.sup.1 and R.sup.2 are taken together to represent a tetramethylene or pentamethylene group; (II) R.sup.1 represents a hydrogen atom, and R.sup.2 represents (1) a cycloalkyl or cycloalkenyl group of 4-7 carbon atoms which is unsubstituted or substituted by at least one alkyl group of 1-4 carbon atoms, (2) an anthryl or naphthyl group, (3) a phenyl group which is unsubstituted or substituted, (4) a heterocyclic group containing at least one of nitrogen, oxygen and sulfur atoms which is unsubstituted or substituted (5) a ##STR2## group (wherein R.sup.4 represents a hydrogen atom, a halogen atom, phenyl group or an alkyl group of 1-5 carbon atoms; and R.sup.5 represents a hydrogen atom, a phenyl group or an alkyl group of 1-5 carbon atoms) or ##STR3## group; or (III) R.sup.1 and R.sup.2, which may be the same or different with each other, each represents a phenyl group which is unsubstituted or substituted; and R.sup.

Abstract: The rhodanine derivatives of the general formula: ##STR1## possess a strong inhibitory activity on aldose reductase, and are useful for the prevention and treatment of nerve disturbances such as neuralgia, retinopathy, diabetic cataract and renal disturbances such as tubular nephropathy.

Abstract: A method for isolating and purifying a physiologically active substance contained in a tissue or a body fluid using an insoluble type naturally occurring proteolytic enzyme inhibitor or an insoluble type proteolytic enzyme alone or in combination with the insoluble type naturally occurring proteolytic enzyme inhibitor is disclosed.